Skip to content

ICS Related

A round-up of some of the most topical research presented at this year’s ESC

Cardiovascular disease is biggest killer globally but cancer overtakes in some countries Cardiovascular disease remains the main cause of death globally, but cancer has overtaken it to become the leading cause of death in some high-income and upper-middle-income countries, according to the late-breaking results from the PURE study, which were presented in a Hot Line…

Read More

Evidence-based approaches to hypertension

A comparison of current European and US guidelines and management principles An estimated 1.13 billion people worldwide have hypertension. It is a major cardiovascular risk factor and a leading risk factor for global deaths. According to the World Health Organisation (WHO), in 2015, one-in-four men and one-in-five women had hypertension and fewer than one-in-five people…

Read More

Managing heart valve disease

As we mark European Heart Valve Disease Awareness Week ( this month (16-22 September), it is important that patients understand that progress and changes in the treatment of heart valve disease make the disease a little less daunting The landscape of cardiac surgery is changing with lightning speed. Cardiac surgery has been the focus of…

Read More

Coming together for cardiac care

Ahead of a landmark conference with the Irish Cardiac Society (ICS) and the Mayo Clinic, US, ICS President Dr Jim Crowley spoke with Pat Kelly about the significance of the event and the overall health of cardiac care in Ireland The conference, titled ‘Cardiology on the Green’, will take place on 4-6 of April in…

Read More

Minimally invasive clipping of the left atrial appendage: Reducing stroke risk in patients with atrial fibrillation

Ms Donna Eaton outlines how device closure of the left atrial appendage has emerged as a safe and effective alternative to anticoagulation for some patients The most serious risk to patients with atrial fibrillation (AF) is thromboembolic stroke. There is a clear relationship between the left atrial appendage (LAA) and stroke in patients with non-valvular…

Read More

Preventing cardiovascular disease in primary care

Dr David Molony documents the success of Heartwatch in primary care to date but bemoans the lack of investment in the programme, which is no longer recruiting patients Heartwatch is the National Programme in General Practice for the Secondary Prevention of Cardiovascular Disease (CVD) in Ireland, as patients with established cardiovascular disease have a high…

Read More

Heart failure and iron deficiency — guidelines and practicalities

Dr Pat O’Callaghan looks at the prevalence, diagnosis and optimal management of iron deficiency in heart failure patients As many as 50 per cent of heart failure patients are iron-deficient. In patients with heart failure, iron deficiency correlates with decreased exercise capacity, with poor quality of life and predicts worse outcomes. Iron deficiency is easily…

Read More

Atrial fibrillation: Prevention and treatment

Dr Angie Brown gives a comprehensive overview of the prevention, diagnosis, treatment options and latest trial data on the management of atrial fibrillation Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Its prevalence is 0.1-to-4 per cent and is constantly increasing. Furthermore, 70 per cent of AF is asymptomatic, so the actual true…

Read More
Scroll To Top